Nine Masts Capital’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-200,660
| Closed | -$2.87M | – | 26 |
|
|
2020
Q4 | $2.87M | Buy |
200,660
+97,650
| +95% | +$1.4M | 2.47% | 10 |
|
|
2020
Q3 | $1.46M | Buy |
+103,010
| New | +$1.46M | 1.15% | 10 |
|
|
2019
Q4 | – | Sell |
-255,250
| Closed | -$1.96M | – | 96 |
|
|
2019
Q3 | $1.96M | Buy |
+255,250
| New | +$1.96M | 0.37% | 24 |
|
|
2019
Q1 | – | Sell |
-31,965
| Closed | -$241K | – | 124 |
|
|
2018
Q4 | $241K | Sell |
31,965
-470,140
| -94% | -$3.54M | 0.04% | 81 |
|
|
2018
Q3 | $3.52M | Sell |
502,105
-177,430
| -26% | -$1.24M | 0.96% | 21 |
|
|
2018
Q2 | $4.4M | Buy |
+679,535
| New | +$4.4M | 0.85% | 23 |
|
|
2018
Q1 | – | Sell |
-220,000
| Closed | -$1.67M | – | 214 |
|
|
2017
Q4 | $1.67M | Buy |
220,000
+167,000
| +315% | +$1.27M | 0.22% | 48 |
|
|
2017
Q3 | $380K | Buy |
+53,000
| New | +$380K | 0.06% | 55 |
|
|
2017
Q2 | – | Sell |
-245,595
| Closed | -$2M | – | 141 |
|
|
2017
Q1 | $2M | Sell |
245,595
-22,875
| -9% | -$186K | 0.34% | 39 |
|
|
2016
Q4 | $2.42M | Sell |
268,470
-10,530
| -4% | -$95K | 0.5% | 33 |
|
|
2016
Q3 | $2.61M | Buy |
279,000
+265,500
| +1,967% | +$2.49M | 0.52% | 38 |
|
|
2016
Q2 | $135K | Sell |
13,500
-78,250
| -85% | -$783K | 0.03% | 52 |
|
|
2016
Q1 | $841K | Sell |
91,750
-981,265
| -91% | -$8.99M | 0.16% | 58 |
|
|
2015
Q4 | $10.1M | Buy |
+1,073,015
| New | +$10.1M | 2.08% | 13 |
|
|
2015
Q3 | – | Sell |
-39,975
| Closed | -$446K | – | 70 |
|
|
2015
Q2 | $446K | Sell |
39,975
-207,470
| -84% | -$2.31M | 0.15% | 52 |
|
|
2015
Q1 | $2.83M | Buy |
+247,445
| New | +$2.83M | 0.58% | 24 |
|